- ►nih.gov M Lüke, M Warga, F Ziemssen, F Gelisken, S … - British Journal of Ophthalmology, 2006 - bjo.bmj.com Background: Bevacizumab (Avastin) is a recombinant protein that targets vascular
endothelial growth factor (VEGF). In vitro, bevacizumab inhibits VEGF induced
cell proliferation and tissue factor production. Abnormal angiogenesis ... Cited by 35 - Related articles - BL Direct - All 7 versions
- ►nih.gov MS Spitzer, B Wallenfels-Thilo, A Sierra, E … - British Journal of Ophthalmology, 2006 - bjo.bmj.com Methods: Monolayer cultures of ARPE19, RGC5, and CEC were used. Bevacizumab
(0.008–2.5 mg/ml), diluted in culture medium, was added to cells that were
growing on cell culture dishes. Cellular proliferative activity was ... Cited by 37 - Related articles - BL Direct - All 8 versions
RAJK MATURI, LA BLEAU, DL WILSON - Retina, 2006 - journals.lww.com Skip Navigation Links Home > March 2006 - Volume 26 - Issue 3 >
Electrophysiologic Findings After Intravitreal Bevacizumab (... ... From the
Vitreo-retinal Service, Midwest Eye Institute, Indianapolis, Indiana. Cited by 107 - Related articles - BL Direct - All 2 versions
L Feiner, EE BARR, YB Shui, NM … - Retina, 2006 - journals.lww.com Skip Navigation Links Home > October 2006 - Volume 26 - Issue 8 > Safety of
Intravitreal Injection of Bevacizumab in Rabbit Ey... ... From the *Department
of Ophthalmology and Visual Sciences, Washington University School of ... Cited by 35 - Related articles - BL Direct - All 3 versions
SJ Bakri, JD Cameron, CA McCannel, JS … - American journal of ophthalmology, 2006 - Elsevier Bevacizumab was injected into the vitreous of one eye of each of eight
Dutch-belted rabbits; the other eye served as a control. Four rabbits received a
dose of 1.25 mg/0.05 ml of bevacizumab intravitreally into one eye, and the ... Cited by 48 - Related articles - All 12 versions
- ►iovs.org UU Inan, B Avci, T Kusbeci, B Kaderli, R Avci … - Investigative Ophthalmology & Visual Science, 2007 - ARVO METHODS. Twenty-four rabbits were divided into two groups, each with two
subgroups. The first group (groups 1 and 2) received 1.25 mg (0.05 mL)
intravitreal bevacizumab, and the second group (groups 3 and 4) received ... Cited by 26 - Related articles - BL Direct - All 3 versions
- ►duanesolution.com S Luthra, R Narayanan, LEA MARQUES, M … - Retina, 2006 - journals.lww.com There was no significant difference (P 0.05) between viabilities of HMVECad
cells treated with bevacizumab and IgG. Conclusion: This study suggests that
bevacizumab, at concentrations at or above the dose normally used in ... Cited by 62 - Related articles - BL Direct - All 6 versions
- ►iovs.org P Heiduschka, H Fietz, S Hofmeister, S … - Investigative ophthalmology & visual science, 2007 - ARVO METHODS. Six cynomolgus monkeys (Macaca fascicularis) were used in this study.
Two compositions of intravitreal injection into the right eyes were performed:
one with commercial Avastin (group 1, four animals) and the other one with ... Cited by 57 - Related articles - BL Direct - All 3 versions
F Ziemssen, M Warga, IM Neuhann, M Leitritz, … - British Medical Journal, 2006 - bjo.bmj.com We conclude that metastatic disease should be considered in the differential
diagnosis of eyelid lesions. The present case emphasises the need for a good
medical history in cases of persistent eyelid swelling. Even in the case of ... Cited by 10 - Related articles - All 6 versions
M Lüke, M Weiergräber, C Brand, SA Siapich, … - Brain Research Protocols, 2005 - Elsevier The electroretinogram (ERG) of the isolated bovine retina serves as a proven
criterion of retinal activity. It is used as a sensitive pharmacological tool
for testing effects of applied drugs and toxins on photoreceptors, and ... Cited by 10 - Related articles - All 3 versions
